SCHEDULE: Aladar Szalay Discloses 8.4% Beneficial Stake in Genelux Corporation
Beneficial Ownership Report
Aladar Szalay has filed an amended Schedule 13G, reporting beneficial ownership of 8.4% of Genelux Corporation's common stock as of June 30, 2025.
Summary
- Aladar Szalay beneficially owns an aggregate of 3,171,508 shares of Genelux Corporation common stock.
- This ownership represents 8.4% of the company's common stock outstanding.
- The percentage is calculated based on 37,760,843 shares of common stock outstanding as of June 30, 2025, as reported in Genelux Corporation's Schedule 14A filed on July 11, 2025.
- Szalay holds sole voting and dispositive power over 1,149,821 shares, which include 599,821 shares held by The Szalay 2010 Retained Annuity Trust and 550,000 shares held by The Szalay 2010 Children's Trust.
- Szalay holds shared voting and dispositive power over 2,021,687 shares, which include 5,000 shares held by his spouse and 2,016,687 shares held jointly with his spouse.
Sentiment
Score: 5
Explanation: This is a neutral, factual filing regarding beneficial ownership and does not contain information that would inherently indicate positive or negative sentiment.
Future Outlook
NA
Industry Context
This filing is a standard disclosure of beneficial ownership by a significant shareholder in a publicly traded company. It provides transparency regarding the ownership structure, which is a routine aspect of corporate governance in the biotechnology or pharmaceutical industry where Genelux Corporation likely operates.
Related Party Transactions
- Aladar Szalay's beneficial ownership includes shares held by The Szalay 2010 Retained Annuity Trust, The Szalay 2010 Children's Trust, shares held by his spouse, and shares held jointly with his spouse.
Stakeholder Impact
- Shareholders gain transparency regarding the significant ownership stake held by Aladar Szalay, which can influence perceptions of stability and insider confidence.
Key Dates
| Date | Description |
|---|---|
| 06/30/2025 | Date of event which requires filing of this statement (beneficial ownership calculation date). |
| 07/11/2025 | Date Genelux Corporation's Schedule 14A was filed, reporting shares outstanding. |
| 07/25/2025 | Date the Schedule 13G Amendment No. 2 was signed by Aladar Szalay. |
Keywords
Genelux Corporation, Aladar Szalay, Beneficial Ownership, Schedule 13G, Common Stock, Shareholder, SEC Filing, Ownership Stake
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.